Brief: Myriad Genetics Q2 Operating Income USD -36.5 Million
06/08/2024 21:05
Aug 06 (Reuters) - Myriad Genetics Q2 gross margin 69.6%. * Q2 adjusted operating expenses USD 140.8 million * Q2 adjusted operating income USD 7.4 million * Q2 operating expenses USD 183.6 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple